Medical and pharmaceutical law: features of palliative care to the pharmaceutical correction of patients with pain syndromes

Journal Title: Фармацевтичний журнал - Year 2015, Vol 3, Issue 3

Abstract

Reform of the modern health care system is aimed at improving access to medicines for patients of different clinical and pharmacological classification, regulatory and legal nomenclature groups. It acquires special importance in the provision of health medical and pharmaceutical care those patients whose disease is incurable, and accompanied by the development of pain. For theese categories of patients (and their in Ukraine more than 400 thousand) at the legislative level, a dedicated view of the medical and pharmaceutical care - palliative care. Therefore, the aim of the work was to study the features of palliative care as a separate pharmaceutical correction of patients with pain from a position of medical and pharmaceutical law. To achieve this goal we used the following materials research: health legislation (Constitution, laws, orders of the Ministry of Health of Ukraine, forms of medicines at all levels), medical and technological documentation regarding the provision of palliative care. The study used the following methods: regulatory, documentary, method of systematic data and forensic pharmaceutical analysis. The study highlighted the category of patients in need of palliative care. The basic clinical and pharmacological group of drugs that are used to pharmaceutical correction pain in palliative patients and their distribution over the levels of anesthesia. It was established that in the provision of palliative care possible use of adjuvant drugs that target potentiating and prolongation of action of drugs with direct analgesic effect. The systematization of clinical and pharmacological groups adjuvant drugs in accordance with international anatomical-therapeutic and chemical classification system ATC. The study authors have outlined the main directions of improvement of palliative care, in particular adjuvant pharmaceutical correction by forming an official list of drugs that can be used as part of adjuvant pharmaceutical correction followed by corresponding changes in their instructions for medical use.

Authors and Affiliations

O. A. Ryschenko

Keywords

Related Articles

The substantiation of plant raw materials ratio and determination of raw materials technological parameters in the development of complex tincture for the telogen effluvium treatment

Telogen effluvium is the most common form of diffuse alopecia in women due to concomitant somatic pathology and adverse exogenous factors. Pharmacotherapy of the disease requires the use of active substances that should...

In silico screening of drug-like molecules for the treatment of cardiovascular diseases on the basis of five-membered privileged heterocycles

Among various heterocyclic systems, the derivatives of five-membered heterocycles are of special interest. Most of the above mentioned heterocycles are treatred as so-called privileged structures in modern medicinal chem...

Cardiotropic action of combined use of celecoxib and amlodipine in rats sicked on adjuvant arthritis coupled with arterial hypertension

Drug therapy of rheumatoid arthritis combined with arterial hypertension is among actual medical objectives. The complexity of pharmacological treatment of comorbid state is due to not only pathological process severity,...

The investigation of the cranberry (Vaccinium oxycoccos L.) concentrated juice antimicrobial activity

The urinary system infections is one of the most common diseases of the genitourinary system in women. Of particular interest in the prevention and treatment of chronic cystitis is the consumption of the cranberry (Vacci...

Analysis of drug group D07 «Corticosteroids for use in dermatology» on the Ukrainian pharmaceutical market

In some cases, ringworm, accompanied by inflammatory reaction of skin treated with combined administration of antifungal drugs and corticosteroids local action. In Ukraine there is an unequal distribution of the producti...

Download PDF file
  • EP ID EP586447
  • DOI -
  • Views 68
  • Downloads 0

How To Cite

O. A. Ryschenko (2015). Medical and pharmaceutical law: features of palliative care to the pharmaceutical correction of patients with pain syndromes. Фармацевтичний журнал, 3(3), 84-92. https://europub.co.uk./articles/-A-586447